Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Pediatrix Medical Group Q2 Adjusted EPS $0.39, Inline, Sales $500.58M Beat $494.47M Estimate

Author: Benzinga Newsdesk | August 03, 2023 06:01am
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.39 per share which met the analyst consensus estimate. This is a 17.02 percent decrease over earnings of $0.47 per share from the same period last year. The company reported quarterly sales of $500.58 million which beat the analyst consensus estimate of $494.47 million by 1.24 percent. This is a 2.99 percent increase over sales of $486.03 million the same period last year.

Posted In: MD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist